Eleonora Alimenti
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach.
Journal: Cancers
Published: February 16, 2026
Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2026
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
The Predictive Role of [18F]FDG PET/CT in Early HCC Recurrence After Liver Transplantation.
Journal: Cancers
Published: January 16, 2026
Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practice.
Journal: JHEP reports : innovation in hepatology
Published: December 12, 2025
Breaking Barriers: Equitable Treatment Access Achieves Survival Parity in HCC for People With HIV.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 10, 2025
Impact of hepatocellular carcinoma on the risk of liver decompensation: A comparative analysis of patients with and without HCC.
Journal: JHEP reports : innovation in hepatology
Published: June 03, 2025
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 18, 2025
ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatments.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 09, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma.
Journal: Hepatology communications
Published: March 18, 2025
Erratum to "Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma" [Digestive and Liver Disease 56 (2024) 2011-2021].
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: December 17, 2024
Last Updated: 09/26/2026